|
ZNF284 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.73190000005452E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.14880000000339E-05 |
| Normal-vs-Stage2 |
7.234200E-04 |
| Normal-vs-Stage3 |
7.33689999976583E-07 |
| Normal-vs-Stage4 |
3.95840000000369E-06 |
| Stage1-vs-Stage2 |
7.381800E-01 |
| Stage1-vs-Stage3 |
4.738000E-02 |
| Stage1-vs-Stage4 |
1.937590E-01 |
| Stage2-vs-Stage3 |
1.033240E-01 |
| Stage2-vs-Stage4 |
1.749990E-01 |
| Stage3-vs-Stage4 |
8.268800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.65603999999764E-05 |
| Normal-vs-AfricanAmerican |
1.508030E-02 |
| Normal-vs-Asian |
5.797100E-04 |
| Caucasian-vs-AfricanAmerican |
4.770200E-01 |
| Caucasian-vs-Asian |
5.252800E-01 |
| AfricanAmerican-vs-Asian |
8.299600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.36810000000731E-05 |
| Normal-vs-Female |
4.3345000000361E-06 |
| Male-vs-Female |
7.086800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.21809999999545E-05 |
| Normal-vs-Age(41-60Yrs) |
1.69770999999264E-05 |
| Normal-vs-Age(61-80Yrs) |
2.08119999999257E-05 |
| Normal-vs-Age(81-100Yrs) |
3.476300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.108600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.805200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.508400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.274800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.811400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.162400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.951600E-02 |
| Classical-VS-Follicular |
2.440600E-01 |
| Classical-VS-Other |
4.757600E-01 |
| Classical-VS-Normal |
7.9656000000039E-05 |
| Tall-VS-Follicular |
2.301800E-01 |
| Tall-VS-Other |
7.442800E-01 |
| Tall-VS-Normal |
9.59410000000993E-07 |
| Follicular-VS-Other |
7.794800E-01 |
| Follicular-VS-Normal |
2.45999999999302E-05 |
| Other-VS-Normal |
3.521800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67549999999994E-05 |
| Normal-vs-N1 |
1.010890E-04 |
| N0-vs-N1 |
8.368000E-01 |
|
|
